Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554096 · ClinicalTrials.gov registry record · NA
Brain Penetrance of 2-HOBA in Humans
A NA study, sponsored by Metabolic Technologies.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03554096 is a NA study that has completed, run by Metabolic Technologies. The registered enrollment target is 3 participants.
The verdict
NCT03554096, a NA study, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm that 2-HOBA crosses the blood brain barrier and to compare blood and cerebrospinal fluid levels of 2-HOBA after a single oral dose.
Interventions
- DIETARY_SUPPLEMENT 2-HOBA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2019-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03554096
The ClinicalTrials.gov registry entry for NCT03554096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metabolic Technologies, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2-HOBA is the first listed.
NCT03554096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03554096 about?
NCT03554096 is a clinical study titled "Brain Penetrance of 2-HOBA in Humans". The purpose of this study is to confirm that 2-HOBA crosses the blood brain barrier and to compare blood and cerebrospinal fluid levels of 2-HOBA after a single oral dose.
What is the current status of trial NCT03554096?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2018-05-23. Estimated completion is 2019-02-08.
What interventions are being tested in trial NCT03554096?
The interventions under investigation include: 2-HOBA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03554096?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.